Terms: = Sarcomas AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS
6 results:
1. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
[TBL] [Abstract] [Full Text] [Related]
2. COL1A2 is a tbx3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
[TBL] [Abstract] [Full Text] [Related]
3. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract] [Full Text] [Related]
4. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
[TBL] [Abstract] [Full Text] [Related]
5. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract] [Full Text] [Related]
6. Intranuclear undulating membranous structures in cells of a human parosteal osteosarcoma.
Murray AB; Büscher H; Erfle V; Biehl T; Gössner W
Ultrastruct Pathol; 1983; 5(2-3):163-70. PubMed ID: 6583881
[TBL] [Abstract] [Full Text] [Related]
